Koetzner L, Deng S, Sumpter T L, Weisslitz M, Abner R T, Landry D W, Woods J H
Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0632, USA.
J Pharmacol Exp Ther. 2001 Mar;296(3):789-96.
Immunization may be a useful pharmacokinetic antagonist therapy for cocaine users. Three rhesus monkeys were immunized with a cocaine:bovine serum albumin conjugate in alum and later with complete and incomplete Freund's adjuvants. Monkeys developed cocaine-binding antibodies (as measured by enzyme-linked immunosorbent assay) after immunization with alum; greater antibody titers developed after immunization with Freund's adjuvants. The response rate-decreasing effect of cocaine diminished in proportion to antibody titer; there was no substantial change in the rate-decreasing effect of bupropion. Plasma cocaine concentrations increased in proportion to antibody titer. Immunizations were well tolerated and had no effect on response rates. These data suggest that the antibody response to a cocaine antigen can produce a specific pharmacokinetic shift in cocaine distribution sufficient to antagonize a behavioral effect of the drug, and can do so with minimal side effects.
免疫接种对于可卡因使用者可能是一种有用的药代动力学拮抗疗法。三只恒河猴用可卡因与明矾中的牛血清白蛋白结合物进行免疫接种,随后用完全和不完全弗氏佐剂进行免疫接种。用明矾免疫后,猴子产生了可卡因结合抗体(通过酶联免疫吸附测定法测量);用弗氏佐剂免疫后产生了更高的抗体滴度。可卡因的反应率降低效应与抗体滴度成比例降低;安非他酮的反应率降低效应没有实质性变化。血浆可卡因浓度与抗体滴度成比例增加。免疫接种耐受性良好,对反应率没有影响。这些数据表明,对可卡因抗原的抗体反应可在可卡因分布中产生特定的药代动力学变化,足以拮抗该药物的行为效应,并且可以在副作用最小的情况下做到这一点。